CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.84
+0.09 (1.57%)
At close: Sep 11, 2026, 4:00 PM EDT
5.78
-0.06 (-1.03%)
After-hours: Sep 11, 2026, 7:30 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $8.53 million as of September 11, 2026. Its market cap has increased by 112.20% in one year.
Market Cap
8.53M
Enterprise Value
-11.45M
1-Year Change
112.20%
Ranking
Category
Stock Price
$5.84
ChartMarket Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $8.53M, a decrease of -87.79%. That is a compound annual growth rate of -26.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 8.53M | 162.09% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences Holdings | 9.75M |
| Xenetic Biosciences | 9.58M |
| Skye Bioscience | 9.05M |
| Exicure | 8.80M |
| Traws Pharma | 8.43M |
| XTL Biopharmaceuticals | 8.35M |
| Imunon | 8.33M |
| Soligenix | 8.12M |